Sabre Corpo Stock Buy Hold or Sell Recommendation
| SABR Stock | USD 2.57 0.04 1.53% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Sabre Corpo is 'Cautious Hold'. Macroaxis provides Sabre Corpo buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding SABR positions. The advice algorithm takes into account all of Sabre Corpo's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Sabre Corpo's buy or sell advice are summarized below:
Real Value 3.2 | Target Price 5.3 | Hype Value 2.61 | Market Value 2.57 | Naive Value 2.24 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Sabre Corpo given historical horizon and risk tolerance towards Sabre Corpo. When Macroaxis issues a 'buy' or 'sell' recommendation for Sabre Corpo, the advice is generated through an automated system that utilizes algorithms and statistical models.
Sabre |
Execute Sabre Corpo Buy or Sell Advice
The Sabre recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Sabre Corpo. Macroaxis does not own or have any residual interests in Sabre Corpo or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Sabre Corpo's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Very risky | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Above Average | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Sabre Corpo Trading Alerts and Improvement Suggestions
| Sabre Corpo generated a negative expected return over the last 90 days | |
| Sabre Corpo has high historical volatility and very poor performance | |
| Sabre Corpo has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 2.91 B. Net Loss for the year was (527.94 M) with profit before overhead, payroll, taxes, and interest of 1.5 B. | |
| Over 90.0% of the company shares are owned by institutional investors | |
| Latest headline from seekingalpha.com: FYBR, BCRX and SABR are among after hour movers |
Sabre Corpo Returns Distribution Density
The distribution of Sabre Corpo's historical returns is an attempt to chart the uncertainty of Sabre Corpo's future price movements. The chart of the probability distribution of Sabre Corpo daily returns describes the distribution of returns around its average expected value. We use Sabre Corpo price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Sabre Corpo returns is essential to provide solid investment advice for Sabre Corpo.
| Mean Return | -0.63 | Value At Risk | -7.28 | Potential Upside | 6.01 | Standard Deviation | 4.85 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Sabre Corpo historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Sabre Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Sabre Corpo is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sabre Corpo backward and forwards among themselves. Sabre Corpo's institutional investor refers to the entity that pools money to purchase Sabre Corpo's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 7 M | Massachusetts Financial Services Company | 2023-12-31 | 5.5 M | Contrarius Investment Management Ltd | 2023-12-31 | 5.2 M | Charles Schwab Investment Management Inc | 2023-12-31 | 5.1 M | Par Capital Management Inc | 2023-12-31 | 5 M | Two Sigma Investments Llc | 2023-12-31 | 4.6 M | Bank Of America Corp | 2023-12-31 | 4.2 M | Two Sigma Advisers, Llc | 2023-12-31 | 4.1 M | Nuveen Asset Management, Llc | 2023-12-31 | 3.6 M | Blackrock Inc | 2023-12-31 | 56.4 M | Vanguard Group Inc | 2023-12-31 | 41.6 M |
Sabre Corpo Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | 33.9M | 99.1M | (52.5M) | 47.5M | 54.7M | 57.4M | |
| Change In Cash | (73.1M) | 1.1B | (500.3M) | (183.5M) | (146.7M) | (139.3M) | |
| Free Cash Flow | 463.7M | (838.6M) | (472.5M) | (349.2M) | (31.6M) | (30.0M) | |
| Depreciation | 414.6M | 363.7M | 262.2M | 184.6M | 148.7M | 253.9M | |
| Other Non Cash Items | 108.9M | 240.6M | 74.0M | (73.4M) | 224.3M | 120.2M | |
| Dividends Paid | 153.5M | 44.4M | 21.6M | 21.4M | (16.0M) | (15.2M) | |
| Capital Expenditures | 115.2M | 65.4M | 54.3M | 69.5M | 87.4M | 145.6M | |
| Net Income | 162.5M | (1.3B) | (926.3M) | (432.8M) | (527.9M) | (501.5M) | |
| End Period Cash Flow | 436.2M | 1.5B | 999.4M | 815.9M | 669.2M | 534.4M | |
| Investments | 5.1M | 2.5M | 24.9M | 174.0M | (92.9M) | (88.3M) | |
| Change Receivables | (33.9M) | 205.0M | (17.9M) | (122.3M) | (110.1M) | (104.6M) | |
| Net Borrowings | (61.6M) | 1.4B | 6.8M | (37.6M) | (43.2M) | (41.0M) | |
| Change To Netincome | 66.0M | 122.0M | 97.8M | (76.0M) | (87.4M) | (83.1M) |
Sabre Corpo Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Sabre Corpo or IT Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Sabre Corpo's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Sabre stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.75 | |
β | Beta against NYSE Composite | 1.88 | |
σ | Overall volatility | 4.97 | |
Ir | Information ratio | -0.14 |
Sabre Corpo Volatility Alert
Sabre Corpo exhibits very low volatility with skewness of -1.42 and kurtosis of 6.42. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Sabre Corpo's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Sabre Corpo's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Sabre Corpo Fundamentals Vs Peers
Comparing Sabre Corpo's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Sabre Corpo's direct or indirect competition across all of the common fundamentals between Sabre Corpo and the related equities. This way, we can detect undervalued stocks with similar characteristics as Sabre Corpo or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Sabre Corpo's fundamental indicators could also be used in its relative valuation, which is a method of valuing Sabre Corpo by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Sabre Corpo to competition |
| Fundamentals | Sabre Corpo | Peer Average |
| Return On Equity | -7.37 | -0.31 |
| Return On Asset | 0.0078 | -0.14 |
| Profit Margin | (0.18) % | (1.27) % |
| Operating Margin | (0.03) % | (5.51) % |
| Current Valuation | 5.22 B | 16.62 B |
| Shares Outstanding | 379.49 M | 571.82 M |
| Shares Owned By Insiders | 1.96 % | 10.09 % |
| Shares Owned By Institutions | 89.85 % | 39.21 % |
| Number Of Shares Shorted | 29.42 M | 4.71 M |
| Price To Earning | 26.39 X | 28.72 X |
| Price To Book | 145.10 X | 9.51 X |
| Price To Sales | 0.35 X | 11.42 X |
| Revenue | 2.91 B | 9.43 B |
| Gross Profit | 1.5 B | 27.38 B |
| EBITDA | 211.61 M | 3.9 B |
| Net Income | (527.94 M) | 570.98 M |
| Cash And Equivalents | 786.61 M | 2.7 B |
| Cash Per Share | 2.40 X | 5.01 X |
| Total Debt | 4.89 B | 5.32 B |
| Current Ratio | 1.89 X | 2.16 X |
| Book Value Per Share | (3.66) X | 1.93 K |
| Cash Flow From Operations | 55.81 M | 971.22 M |
| Short Ratio | 5.04 X | 4.00 X |
| Earnings Per Share | (1.56) X | 3.12 X |
| Price To Earnings To Growth | 1.36 X | 4.89 X |
| Target Price | 4.33 | |
| Number Of Employees | 6.23 K | 18.84 K |
| Beta | 1.79 | -0.15 |
| Market Capitalization | 980.99 M | 19.03 B |
| Total Asset | 4.67 B | 29.47 B |
| Retained Earnings | (4.05 B) | 9.33 B |
| Working Capital | 243.88 M | 1.48 B |
| Current Asset | 778.09 M | 9.34 B |
Note: Disposition of 715 shares by Mandel Gail of Sabre Corpo at 5.56 subject to Rule 16b-3 [view details]
Sabre Corpo Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Sabre . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 201077.0 | |||
| Daily Balance Of Power | (0.29) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 2.63 | |||
| Day Typical Price | 2.61 | |||
| Price Action Indicator | (0.08) | |||
| Period Momentum Indicator | (0.04) |
About Sabre Corpo Buy or Sell Advice
When is the right time to buy or sell Sabre Corpo? Buying financial instruments such as Sabre Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 4.8B | 4.7B | 4.9B | 4.2B | Total Assets | 5.3B | 5.0B | 4.7B | 5.8B |
Use Investing Ideas to Build Portfolios
In addition to having Sabre Corpo in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run World Allocation Funds Thematic Idea Now
World Allocation Funds
Funds or Etfs investing in stocks, bonds, and cash of domestic markets as well as in markets of Canada, Japan, and Europe. The World Allocation Funds theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize World Allocation Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Sabre Corpo Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Sabre Stock, please use our How to Invest in Sabre Corpo guide.Note that the Sabre Corpo information on this page should be used as a complementary analysis to other Sabre Corpo's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Complementary Tools for Sabre Stock analysis
When running Sabre Corpo's price analysis, check to measure Sabre Corpo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sabre Corpo is operating at the current time. Most of Sabre Corpo's value examination focuses on studying past and present price action to predict the probability of Sabre Corpo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sabre Corpo's price. Additionally, you may evaluate how the addition of Sabre Corpo to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |
Is Sabre Corpo's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sabre Corpo. If investors know Sabre will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sabre Corpo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.13) | Earnings Share (1.56) | Revenue Per Share 8.39 | Quarterly Revenue Growth 0.089 | Return On Assets 0.0078 |
The market value of Sabre Corpo is measured differently than its book value, which is the value of Sabre that is recorded on the company's balance sheet. Investors also form their own opinion of Sabre Corpo's value that differs from its market value or its book value, called intrinsic value, which is Sabre Corpo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sabre Corpo's market value can be influenced by many factors that don't directly affect Sabre Corpo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sabre Corpo's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sabre Corpo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sabre Corpo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.